FAKTOR-OPTIONSSCHEIN - LEIDOS Stock

Certificat

DE000MD5Z9A0

Market Closed - Börse Stuttgart 03:19:39 2024-05-28 pm EDT
3.29 EUR +8.22% Intraday chart for FAKTOR-OPTIONSSCHEIN - LEIDOS
Current month-11.08%
1 month-23.13%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-28 3.29 +8.22%
24-05-27 3.04 -3.49%
24-05-24 3.15 -1.87%
24-05-23 3.21 +0.63%
24-05-22 3.19 0.00%

Delayed Quote Börse Stuttgart

Last update May 28, 2024 at 03:19 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying LEIDOS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MD5Z9A
ISINDE000MD5Z9A0
Date issued 2022-07-07
Strike 226.7 $
Maturity Unlimited
Parity 22.25 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 13.24
Lowest since issue 3.04
Spread 0.01
Spread %0.30%

Company Profile

Leidos Holdings, Inc. specializes in the provision of engineering, technological and scientific services. Net sales by business segment break down as follows: - defense (56.6%): design, engineering and integration of technological solutions for intelligence, airborne surveillance and reconnaissance, maritime and land-based solutions, electronic warfare systems, and automated sensor, alarm, command and control systems, software development, cyber security solutions and data processing and analysis solutions, IT infrastructure development and integration, etc.; - civil security (23.7%): development and integration of solutions for the protection of goods, data and digital information, solutions and systems for air traffic flow control and flight data management, vehicle and cargo inspection, explosives and radiation detection, computer security, environmental management, nuclear security, complex logistics management, etc.; - health (19.7%): integration of complex systems and technological infrastructures for the management of data, medical information and electronic health records, provision of healthcare services, IT systems lifecycle management, research and development of biopharmaceuticals, etc. Net sales by market are divided between the US Department of Defense and the intelligence community (49.4%), government agencies (37.4%) and commercial customers (13.2%). The United States accounts for 91,4% of net sales.
Sector
-
More about the company

Ratings for Leidos Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Leidos Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
147.6 USD
Average target price
158.5 USD
Spread / Average Target
+7.37%
Consensus